80 FR 81834 - National Institute on Drug Abuse; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 251 (December 31, 2015)

Page Range		81834-81835
FR Document		2015-32938

Federal Register, Volume 80 Issue 251 (Thursday, December 31, 2015)

[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Pages 81834-81835]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32938]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Council on Drug Abuse.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: February 10, 2016.
    Closed: 8:30 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Open: 10:30 a.m. to 4:00 p.m.

[[Page 81835]]

    Agenda: This portion of the meeting will be open to the public 
for announcements and reports of administrative, legislative, and 
program developments in the drug abuse field.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of 
Extramural Research, Office of the Director, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC 
9591, Rockville, MD 20892, 301-443-6487, [email protected].
    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: December 28, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32938 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P

81834 Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices

and Research Support Awards., National Date: February 23–24, 2016. Extramural Activities, National Cancer
Institutes of Health, HHS) Time: 8:00 a.m. to 1:00 p.m. Institute, NIH, 9609 Medical Center Drive,
Agenda: To review and evaluate grant Room 7W126, Bethesda, MD 20892–9750,
Dated: December 28, 2015.
applications. 240–276–6348, lymanc@mail.nih.gov.
Melanie J. Gray, Place: Bethesda North Marriott Hotel & (Catalogue of Federal Domestic Assistance
Program Analyst, Office of Federal Advisory Conference Center, 5701 Marinelli Road, Program Nos. 93.392, Cancer Construction;
Committee Policy. Bethesda, MD 20852. 93.393, Cancer Cause and Prevention
[FR Doc. 2015–32941 Filed 12–30–15; 8:45 am] Contact Person: Tushar Baran Deb, Ph.D., Research; 93.394, Cancer Detection and
BILLING CODE 4140–01–P
Scientific Review Officer, Research and Diagnosis Research; 93.395, Cancer
Training Review Branch, Division of Treatment Research; 93.396, Cancer Biology
Extramural Activities, National Cancer Research; 93.397, Cancer Centers Support;
Institute, NIH, 9609 Medical Center Drive, 93.398, Cancer Research Manpower; 93.399,
DEPARTMENT OF HEALTH AND Room 7W624, Rockville, MD 20850, 240–
HUMAN SERVICES Cancer Control, National Institutes of Health,
276–6132 tushar.deb@nih.gov. HHS)
National Institutes of Health Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee Dated: December 28, 2015.
J—Career Development. Melanie J. Gray,
National Cancer Institute; Notice of
Date: March 2–3, 2016. Program Analyst, Office of Federal Advisory
Closed Meetings Time: 6:00 p.m. to 4:00 p.m. Committee Policy.
Pursuant to section 10(d) of the Agenda: To review and evaluate grant [FR Doc. 2015–32935 Filed 12–30–15; 8:45 am]
Federal Advisory Committee Act, as applications.
BILLING CODE 4140–01–P
amended (5 U.S.C. App.), notice is Place: Bethesda Marriott, Suites 6711,
Democracy Boulevard, Bethesda, MD 20817.
hereby given of the following meetings. Contact Person: Robert E. Bird, Ph.D.,
The meetings will be closed to the Scientific Review Officer, Research and DEPARTMENT OF HEALTH AND
public in accordance with the Training Review Branch, Division of HUMAN SERVICES
provisions set forth in sections Extramural Activities, National Cancer
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Institute, NIH, 9609 Medical Center Drive, National Institutes of Health
as amended. The grant and contract Room 7W110, Bethesda, MD 20892, 240–
applications and the discussions could 276–6344, birdr@mail.nih.gov. National Institute on Drug Abuse;
disclose confidential trade secrets or Name of Committee: National Cancer Notice of Meeting
commercial property such as patentable Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–1. Pursuant to section 10(d) of the
material, and personal information
Date: March 3–4, 2016. Federal Advisory Committee Act, as
concerning individuals associated with
Time: 8:00 a.m. to 6:00 p.m. amended (5 U.S.C. App.), notice is
the grant and contract applications, the
Agenda: To review and evaluate grant hereby given of a meeting of the
disclosure of which would constitute a applications. National Advisory Council on Drug
clearly unwarranted invasion of Place: Doubletree by Hilton Bethesda, 8120 Abuse.
personal privacy. Wisconsin Avenue, Bethesda, MD 20814. The meeting will be open to the
Name of Committee: National Cancer Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
public as indicated below, with
Institute Special Emphasis Panel; NCI SBIR attendance limited to space available.
Targeted Radiation Therapy. Branch, Division of Extramural Activities,
Date: January 27, 2016. National Cancer Institute, NIH, 9609 Medical Individuals who plan to attend and
Time: 10:30 a.m. to 6:30 p.m. Center Drive, Room 7W242, Bethesda, MD need special assistance, such as sign
Agenda: To review and evaluate contract 20892, 240–276–6372, zouzhiq@mail.nih.gov. language interpretation or other
applications. Name of Committee: National Cancer reasonable accommodations, should
Place: National Cancer Institute Shady Institute Special Emphasis Panel; Cancer notify the Contact Person listed below
Grove, 9609 Medical Center Drive, Room Diagnosis. in advance of the meeting.
7W538, Rockville, MD 20850, (Telephone Date: April 4–5, 2016. The meeting will be closed to the
Conference Call). Time: 8:30 a.m. to 12:00 p.m. public in accordance with the
Contact Person: Ivan Ding, MD, Scientific Agenda: To review and evaluate contract
Review Officer, Special Review Branch, provisions set forth in sections
applications.
Division of Extramural Activities, National Place: Bethesda North Marriott Hotel & 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Cancer Institute, NIH, 9609 Medical Center Conference Center, 5701 Marinelli Road, as amended. The grant applications
Drive, Room 7W412, Bethesda, MD 20892– Bethesda, MD 20852. and/or contract proposals and the
9750, 240–276–6444, dingi@mail.nih.gov. Contact Person: Bratin K. Saha, Ph.D., discussions could disclose confidential
Name of Committee: National Cancer Program Coordination & Referral Branch, trade secrets or commercial property
Institute Special Emphasis Panel; Physical Division of Extramural Activities, National such as patentable material, and
Sciences-Oncology Projects. Cancer Institute, NIH, 9609 Medical Center personal information concerning
Date: February 9–10, 2016. Drive, Room 7W556, Rockville, MD 20850, individuals associated with the grant
Time: 6:00 p.m. to 6:00 p.m. 240–276–6411, sahab@mail.nih.gov.
applications and/or contract proposals,
Agenda: To review and evaluate grant Name of Committee: National Cancer
applications. the disclosure of which would
Institute Special Emphasis Panel; NCI
Place: Doubletree by Hilton Bethesda, 8120 constitute a clearly unwarranted
Provocative Questions Review—PQ 12.
Wisconsin Avenue, Bethesda, MD 20814. Date: April 6, 2016. invasion of personal privacy.
Contact Person: Gerald G. Lovinger, Ph.D., Time: 10:00 a.m. to 12:00 p.m. Name of Committee: National Advisory
Scientific Review Officer, Research and Agenda: To review and evaluate grant Council on Drug Abuse.
Technology and Contract Review Branch, applications. Date: February 10, 2016.
tkelley on DSK3SPTVN1PROD with NOTICES

Division of Extramural Activities, National Place: National Cancer Institute, Shady Closed: 8:30 a.m. to 10:00 a.m.
Cancer Institute, NIH, 9609 Medical Center Grove, 9609 Medical Center Drive, Room Agenda: To review and evaluate grant
Drive, Room 7W266, Bethesda, MD 20892, 7W126, Rockville, MD 20850, (Telephone applications and/or proposals.
240–276–6385, lovingeg@mail.nih.gov. Conference Call). Place: National Institutes of Health,
Name of Committee: National Cancer Contact Person: Caron A. Lyman, Ph.D., Neuroscience Center, 6001 Executive
Institute Initial Review Group; Subcommittee Chief, Scientific Review Officer, Research Boulevard, Rockville, MD 20852.
I-Transition to Independence. Program Review Branch, Division of Open: 10:30 a.m. to 4:00 p.m.

VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\31DEN1.SGM 31DEN1

Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices 81835

Agenda: This portion of the meeting will the discussions could disclose Dea, Niddk, National Institutes of Health,
be open to the public for announcements and confidential trade secrets or commercial Room 753, 6707 Democracy Boulevard,
reports of administrative, legislative, and property such as patentable material, Bethesda, MD 20892–2542, (301) 594–8898,
program developments in the drug abuse and personal information concerning barnardm@extra.niddk.nih.gov.
field.
Place: National Institutes of Health,
individuals associated with the grant Name of Committee: National Institute of
Neuroscience Center, 6001 Executive applications, the disclosure of which Diabetes and Digestive and Kidney Diseases
Boulevard, Rockville, MD 20852. would constitute a clearly unwarranted Special Emphasis Panel—PAR–15–067:
Contact Person: Susan R.B. Weiss, Ph.D., invasion of personal privacy. NIDDK Multi-Center Clinical Study (U01).
Director, Division of Extramural Research, Name of Committee: National Institute of Date: February 8, 2016.
Office of the Director, National Institute on Diabetes and Digestive and Kidney Diseases Time: 12:00 p.m. to 2:00 p.m.
Drug Abuse, NIH, DHHS, 6001 Executive Special Emphasis Panel, T1D Risk Agenda: To review and evaluate grant
Boulevard, NSC, Room 5274, MSC 9591, Assessment and Early Intervention applications.
Rockville, MD 20892, 301–443–6487, Technologies (SBIR). Place: National Institutes of Health, Two
sweiss@nida.nih.gov. Date: January 25, 2016. Democracy Plaza, 6707 Democracy
Any member of the public interested in Time: 11:00 a.m. to 1:00 p.m. Boulevard, Bethesda, MD 20892 (Telephone
presenting oral comments to the committee Agenda: To review and evaluate grant Conference Call).
may notify the Contact Person listed on this applications.
notice at least 10 days in advance of the Contact Person: Dianne Camp, Ph.D.,
Place: National Institutes of Health, Two
meeting. Interested individuals and Democracy Plaza, 6707 Democracy Scientific Review Officer, Review Branch,
representatives of organizations may submit Boulevard, Bethesda, MD 20892 (Telephone Dea, Niddk, National Institutes of Health,
a letter of intent, a brief description of the Conference Call). Room 756, 6707 Democracy Boulevard,
organization represented, and a short Contact Person: Thomas A. Tatham, Ph.D., Bethesda, Md 20892–2542, 301–5947682,
description of the oral presentation. Only one Scientific Review Officer, Review Branch, campd@extra.niddk.nih.gov.
representative of an organization may be Dea, Niddk, National Institutes of Health, (Catalogue of Federal Domestic Assistance
allowed to present oral comments and if Room 760, 6707 Democracy Boulevard,
Program Nos. 93.847, Diabetes,
accepted by the committee, presentations Bethesda, MD 20892–5452, (301) 594–3993,
may be limited to five minutes. Both printed tathamt@mail.nih.gov. Endocrinology and Metabolic Research;
and electronic copies are requested for the 93.848, Digestive Diseases and Nutrition
Name of Committee: National Institute of
record. In addition, any interested person Diabetes and Digestive and Kidney Diseases Research; 93.849, Kidney Diseases, Urology
may file written comments with the Special Emphasis Panel, Closed Loop and Hematology Research, National Institutes
committee by forwarding their statement to Diabetes Technology (SBIR). of Health, HHS)
the Contact Person listed on this notice. The Date: January 28, 2016. Dated: December 24, 2015.
statement should include the name, address, Time: 2:00 p.m. to 5:00 p.m.
telephone number and when applicable, the Agenda: To review and evaluate grant David Clary,
business or professional affiliation of the applications. Program Analyst, Office of Federal Advisory
interested person. Place: National Institutes of Health, Two Committee Policy.
Information is also available on the Democracy Plaza, 6707 Democracy [FR Doc. 2015–32910 Filed 12–30–15; 8:45 am]
Institute’s/Center’s home page: Boulevard, Bethesda, MD 20892 (Telephone
Conference Call). BILLING CODE 4140–01–P
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and Contact Person: Thomas A. Tatham, Ph.D.,
any additional information for the meeting Scientific Review Officer, Review Branch,
will be posted when available. Dea, Niddk, National Institutes of Health, DEPARTMENT OF HEALTH AND
Room 760, 6707 Democracy Boulevard, HUMAN SERVICES
(Catalogue of Federal Domestic Assistance
Bethesda, MD 20892–5452, (301) 594–3993,
Program Nos.: 93.279, Drug Abuse and
tathamt@mail.nih.gov. National Institutes of Health
Addiction Research Programs, National
Institutes of Health, HHS) Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases National Cancer Institute; Amended
Dated: December 28, 2015. Special Emphasis Panel, NIDDK DEM
Natasha M. Copeland, Fellowship Grant Review.
Notice of Meeting
Program Analyst, Office of Federal Advisory Date: January 31–February 2, 2016.
Time: 6:00 p.m. to 5:00 p.m. Notice is hereby given of a change in
Committee Policy.
Agenda: To review and evaluate grant the meeting of the National Cancer
[FR Doc. 2015–32938 Filed 12–30–15; 8:45 am]
applications. Institute Special Emphasis Panel,
BILLING CODE 4140–01–P Place: Melrose Hotel, 2430 Pennsylvania February 2–3, 2016 08:00 a.m. to 05:00
Ave. NW., Washington, DC 20037. p.m., Hilton Washington DC/Rockville,
Contact Person: Carol J. Goter-Robinson,
DEPARTMENT OF HEALTH AND Ph.D., Scientific Review Officer, Review
Rockville, MD 20852 which was
HUMAN SERVICES Branch, Dea, Niddk, National Institutes of published in the Federal Register on
Health, Room 748, 6707 Democracy December 7, 2015 80 FR 76026.
National Institutes of Health Boulevard, Bethesda, MD 20892–5452, (301) The meeting notice is amended to
594–7791, goterrobinsonc@
extra.niddk.nih.gov.
change the title from ‘‘NCI P01 Meeting
National Institute of Diabetes and
II’’ to ‘‘NCI Program Project Meeting III’’.
Digestive and Kidney Diseases; Notice Name of Committee: National Institute of
of Closed Meetings Diabetes and Digestive and Kidney Diseases The meeting is closed to the public.
Special Emphasis Panel, NEW NIDDK PARs Dated: December 28, 2015.
Pursuant to section 10(d) of the on Pragmatic Research and Natural
Melanie J. Gray,
Federal Advisory Committee Act, as Experiments.
Program Analyst, Office of Federal Advisory
tkelley on DSK3SPTVN1PROD with NOTICES

amended (5 U.S.C. App.), notice is Date: February 8, 2016.
Time: 8:00 a.m. to 5:00 p.m. Committee Policy.
hereby given of the following meetings.
Agenda: To review and evaluate grant [FR Doc. 2015–32936 Filed 12–30–15; 8:45 am]
The meetings will be closed to the applications.
public in accordance with the Place: Bethesda Marriott Suites, 6711
BILLING CODE 4140–01–P
provisions set forth in sections Democracy Boulevard, Bethesda, MD 20817.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Michele L. Barnard, Ph.D.,
as amended. The grant applications and Scientific Review Officer, Review Branch,

VerDate Sep<11>2014 16:49 Dec 30, 2015 Jkt 238001 PO 00000 Frm 00031 Fmt 4703 Sfmt 9990 E:\FR\FM\31DEN1.SGM 31DEN1

Document Created: 2015-12-31 02:14:33
Document Modified: 2015-12-31 02:14:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		February 10, 2016.
FR Citation		80 FR 81834

80 FR 81834 - National Institute on Drug Abuse; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 251 (December 31, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health